Dynavax Technologies Corporation (LON:0IDA)
London · Delayed Price · Currency is GBP · Price in USD 10.29
+0.14 (1.41%)
At close: Oct 24, 2025
Dynavax Technologies Market Cap
Dynavax Technologies has a market cap or net worth of 914.9 million as of October 24, 2025. Its market cap has decreased by -13.74% in one year.
Market Cap
914.90M
Enterprise Value
671.25M
Revenue
230.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.29
Market Cap Chart
Since February 19, 2004, Dynavax Technologies's market cap has increased from 117.61M to 914.90M, an increase of 677.89%. That is a compound annual growth rate of 9.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 914.90M | -31.77% |
| Dec 31, 2024 | 1.34B | -5.49% |
| Dec 29, 2023 | 1.42B | 25.92% |
| Dec 30, 2022 | 1.13B | -9.61% |
| Dec 31, 2021 | 1.25B | 247.10% |
| Dec 31, 2020 | 359.09M | -0.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.78B |
| GSK plc | 66.21B |
| Haleon | 31.28B |
| Smith & Nephew | 11.67B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 3.92B |
| HUTCHMED (China) | 1.97B |
| Genus | 1.71B |